CORDIS
EU research results

CORDIS

English EN

ground-breaking PEROvskite technologies for advanced X-ray medical Imaging Systems

Project information

Grant agreement ID: 871336

Status

Ongoing project

  • Start date

    1 January 2020

  • End date

    31 December 2022

Funded under:

H2020-EU.2.1.1.

  • Overall budget:

    € 5 977 498,75

  • EU contribution

    € 5 977 498,25

Coordinated by:

COMMISSARIAT A L ENERGIE ATOMIQUE ET AUX ENERGIES ALTERNATIVES

France

Objective

The PEROXIS project will develop a new X-ray imaging system with higher sensitivity and spatial resolution compared to conventional ones, which will support diagnosis during intervention and treatments of various diseases.
The emerging semiconducting perovskite materials, largely used for photovoltaic applications, are a good candidate since they have the potential to globally address the following ambitious objectives:
-Advancing X-ray based imaging systems for advanced diagnostics and treatments of two major diseases: cardiovascular disease (CVD) and chronic obstructive pulmonary disease (COPD)
-Improving the efficiency and spatial resolution of flat panel X-ray detectors
-Groundbreaking perovskite-based direct conversion X-ray imaging detectors for large-area compatibility
-Validating the feasibility of phase contrast imaging for earlier detection of chronic obstructive pulmonary disease
PEROXIS is a multidisciplinary project engaging 7 EU partners from 4 countries (France, Germany, Spain and the Netherlands) covering the academic, RTO and industrial (3 major medical equipment manufacturers) worlds. An implementation plan is presented in the form of 8 work packages, 6 of which are technical in nature. Synergy in communication and dissemination by the several partners and stakeholders (external advisory board mainly composed of physicians who provide letters of intent) will permit to maximize the PEROXIS project impact.
Both solutions to overcome the fundamental technological barriers as well as appropriate deliverables, tasks, milestones and risks in order to complete the project objectives in due time are presented. The medical sector will be highly impacted by the PEROXIS project outcome: future applications of an improved PEROXIS imaging system will not be limited to COPD and CVD only, but may be extended to various other clinical domains in which the performance of diagnostic driven therapy systems is limited by current flat panel X-ray detector technology.

Coordinator

COMMISSARIAT A L ENERGIE ATOMIQUE ET AUX ENERGIES ALTERNATIVES

Address

Rue Leblanc 25
75015 Paris 15

France

Activity type

Research Organisations

EU Contribution

€ 1 198 478,75

Participants (7)

TRIXELL

France

EU Contribution

€ 1 189 798,75

SIEMENS HEALTHCARE GMBH

Germany

EU Contribution

€ 731 070

UNIVERSITAT JAUME I DE CASTELLON

Spain

EU Contribution

€ 376 032

PHILIPS ELECTRONICS NEDERLAND BV

Netherlands

EU Contribution

€ 882 500

NEDERLANDSE ORGANISATIE VOOR TOEGEPAST NATUURWETENSCHAPPELIJK ONDERZOEK TNO

Netherlands

EU Contribution

€ 700 243,75

CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE CNRS

France

EU Contribution

€ 623 750

PHILIPS MEDICAL SYSTEMS NEDERLAND BV

Netherlands

EU Contribution

€ 275 625

Project information

Grant agreement ID: 871336

Status

Ongoing project

  • Start date

    1 January 2020

  • End date

    31 December 2022

Funded under:

H2020-EU.2.1.1.

  • Overall budget:

    € 5 977 498,75

  • EU contribution

    € 5 977 498,25

Coordinated by:

COMMISSARIAT A L ENERGIE ATOMIQUE ET AUX ENERGIES ALTERNATIVES

France